• -58%
  • New

CSA Z23500-1:20

$95.00
$39.90 Save 58%

CSA Z23500-1:20 Preparation and quality management of fluids for haemodialysis and related therapies - Part 1: General requirements (Adopted ISO 23500-1: 2019, first edition, 2019-02, with Canadian deviations)

standard by CSA Group, 01/01/2020

Quantity
In stock

Full Description

Preface:

This is the first edition of CSA Z23500-1, Preparation and quality management of fluids for haemodialysis and related therapies Part 1: General requirements, which is an adoption, with Canadian deviations, of the identically titled ISO (International Organization for Standardization) Standard 23500-1 (first edition, 2019-02). It replaces CAN/CSA-Z23500:16 (adopted ISO 23500:2014), Guidance for the preparation and quality management of fluids for haemodialysis and related therapies.

This Standard has been developed in compliance with Standards Council of Canada requirements for National Standards of Canada. It has been published as a National Standard of Canada by CSA Group.

Scope:

1.1 General
This document is the base standard for a number of other standards dealing with water treatment equipment, water, dialysis water, concentrates, and dialysis fluid (ISO 23500 series) and provides dialysis practitioners with guidance on the preparation of dialysis fluid for haemodialysis and related therapies and substitution fluid for use in online therapies, such as haemodiafiltration and haemofiltration. As such, this document functions as a recommended practice.

This document does not address clinical issues that might be associated with inappropriate usage of the water, dialysis water, concentrates, or dialysis fluid. Healthcare professionals involved in the provision of treatment for kidney failure should make the final decision regarding the applications with which these fluids are used, for example, haemodialysis, haemodiafiltration, high-flux haemodialysis, and the reprocessing of dialysers, and need to be aware of the issues that the use of inappropriate fluid quality raises in each of the therapies.

The concepts incorporated in this document should not be considered inflexible or static. The recommendations presented here should be reviewed periodically in order to assimilate increased understanding of the role of dialysis fluid purity in patient outcomes and technological developments.

1.2 Inclusions
This document addresses the user's responsibility for dialysis fluid once the equipment used in its preparation has been delivered and installed.

For the purposes of this document, dialysis fluid includes:
a) dialysis water (see 3.17 for definition) used for the preparation of dialysis fluid and substitution fluid
b) dialysis water used for the preparation of concentrates at the user's facility
c) concentrates
d) the final dialysis fluid and substitution fluid.

The scope of this document includes
a) the quality management of equipment used to treat and distribute water used for the preparation of dialysis fluid and substitution fluid, from the point at which municipal water enters the dialysis facility to the point at which the final dialysis fluid enters the dialyser or the point at which substitution fluid is infused
b) equipment used to prepare concentrate from powder or other highly concentrated media at a dialysis facility, and
c) preparation of the final dialysis fluid or substitution fluid from dialysis water and concentrates.

NOTE Because water used to prepare dialysis fluid can also be used to reprocess dialysers not marked intended for single use, this aspect of water use is also covered by this document.

1.3 Exclusions
This document does not apply to sorbent-based dialysis fluid regeneration systems that regenerate and recirculate small volumes of dialysis fluid, systems for continuous renal replacement therapy that use pre-packaged solutions, and systems and solutions for peritoneal dialysis.

M00065958
2021-02-18
New product